ကျိၣ်စ့တၢ်ဂ့ၢ်တၢ်ကျိၤ
တၢ်ဃ့က့ၤအဘူးအလဲ ဒီးတၢ်ပတံသကွံာ်ကညးတၢ်တဖၣ်
Vision Direct Reimbursement Claim Form
လံာ်တီလံာ်မီတဖၣ်ဒီး လံာ်ကွီၣ်ဒိတဖၣ်အစၢတဖၣ်
တၢ်ပာ်ဖျါ 2281 - 2290 လၢ 3563 အစၢတဖၣ်အကျါ
သဲစး ဒီး တၢ်ဖီၣ်ဂၢၢ်တၢ်သိၣ်တၢ်သီ
Disabled Dependent Application
သဲစး ဒီး တၢ်ဖီၣ်ဂၢၢ်တၢ်သိၣ်တၢ်သီ
P11GA_17131859-ADHI_form_X21006R04_Hmong.pdf
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP3-20 Addition of Mille Lacs Corporate Ventures to the American Indian Tribal Fee Schedule for Eligible Facility and Professional Services Provided to Purchased/Referred Care (PRC) – Eligible American Indians
တၢ်ရဲၣ်တၢ်ကျၢၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယနူၤအါရံၤ 08, 2020
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP2-20 MHCP Medical Dental Claim Denials
တၢ်ရဲၣ်တၢ်ကျၢၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယနူၤအါရံၤ 08, 2020
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP40R1-19 Medical Drug Update for Drug Golodirsen (Vyondys 53)
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 13, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP40-19 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 13, 2019
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P1-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective March 2, 2020
တၢ်ရဲၣ်တၢ်ကျၢၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယနူၤအါရံၤ 02, 2020